Phase III trial of capecitabine + oxaliplatin (XELOX) vs. 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (FOLFOX4) as 2nd-line treatment for patients with metastatic colorectal cancer (MCRC) - Rothenberg, M L (Journal of Clinical Oncology, 2007)
ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2007